175 related articles for article (PubMed ID: 29147930)
1. SNP association study in PMS2-associated Lynch syndrome.
Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.
Goverde A; Spaander MCW; Nieboer D; van den Ouweland AMW; Dinjens WNM; Dubbink HJ; Tops CJ; Ten Broeke SW; Bruno MJ; Hofstra RMW; Steyerberg EW; Wagner A
Fam Cancer; 2018 Jul; 17(3):361-370. PubMed ID: 28933000
[TBL] [Abstract][Full Text] [Related]
6. Cancer Risks for PMS2-Associated Lynch Syndrome.
Ten Broeke SW; van der Klift HM; Tops CMJ; Aretz S; Bernstein I; Buchanan DD; de la Chapelle A; Capella G; Clendenning M; Engel C; Gallinger S; Gomez Garcia E; Figueiredo JC; Haile R; Hampel HL; Hopper JL; Hoogerbrugge N; von Knebel Doeberitz M; Le Marchand L; Letteboer TGW; Jenkins MA; Lindblom A; Lindor NM; Mensenkamp AR; Møller P; Newcomb PA; van Os TAM; Pearlman R; Pineda M; Rahner N; Redeker EJW; Olderode-Berends MJW; Rosty C; Schackert HK; Scott R; Senter L; Spruijt L; Steinke-Lange V; Suerink M; Thibodeau S; Vos YJ; Wagner A; Winship I; Hes FJ; Vasen HFA; Wijnen JT; Nielsen M; Win AK
J Clin Oncol; 2018 Oct; 36(29):2961-2968. PubMed ID: 30161022
[TBL] [Abstract][Full Text] [Related]
7. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
van der Klift HM; Mensenkamp AR; Drost M; Bik EC; Vos YJ; Gille HJ; Redeker BE; Tiersma Y; Zonneveld JB; García EG; Letteboer TG; Olderode-Berends MJ; van Hest LP; van Os TA; Verhoef S; Wagner A; van Asperen CJ; Ten Broeke SW; Hes FJ; de Wind N; Nielsen M; Devilee P; Ligtenberg MJ; Wijnen JT; Tops CM
Hum Mutat; 2016 Nov; 37(11):1162-1179. PubMed ID: 27435373
[TBL] [Abstract][Full Text] [Related]
10. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
[TBL] [Abstract][Full Text] [Related]
11. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
[TBL] [Abstract][Full Text] [Related]
12. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.
Chau R; Dashti SG; Ait Ouakrim D; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Macrae FA; Boussioutas A; Parry S; Figueiredo JC; Levine AJ; Ahnen DJ; Casey G; Haile RW; Gallinger S; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
Int J Epidemiol; 2016 Jun; 45(3):940-53. PubMed ID: 27063605
[TBL] [Abstract][Full Text] [Related]
13. PMS2 expression decrease causes severe problems in mismatch repair.
Kasela M; Nyström M; Kansikas M
Hum Mutat; 2019 Jul; 40(7):904-907. PubMed ID: 30946512
[TBL] [Abstract][Full Text] [Related]
14. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
15. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.
Haraldsdottir S; Rafnar T; Frankel WL; Einarsdottir S; Sigurdsson A; Hampel H; Snaebjornsson P; Masson G; Weng D; Arngrimsson R; Kehr B; Yilmaz A; Haraldsson S; Sulem P; Stefansson T; Shields PG; Sigurdsson F; Bekaii-Saab T; Moller PH; Steinarsdottir M; Alexiusdottir K; Hitchins M; Pritchard CC; de la Chapelle A; Jonasson JG; Goldberg RM; Stefansson K
Nat Commun; 2017 May; 8():14755. PubMed ID: 28466842
[TBL] [Abstract][Full Text] [Related]
18. Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
Villacis RA; Miranda PM; Gomy I; Santos EM; Carraro DM; Achatz MI; Rossi BM; Rogatto SR
Int J Cancer; 2016 Apr; 138(8):1928-35. PubMed ID: 26620301
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of the PREMM
Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S
J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]